
July 7 (Reuters) - UK's MHRA:
MHRA: THERE IS SMALL INCREASE IN RISK OF GUILLAIN-BARRÉ SYNDROME POST VACCINATION WITH ABRYSVO AND AREXVY IN ADULTS AGED 60 YEARS & OLDER -WEBSITE
UK'S MHRA: COMMISSION ON HUMAN MEDICINES ADVISE THAT BENEFITS OF VACCINATION AGAINST RSV OUTWEIGH SMALL RISK OF DEVELOPING GUILLAIN-BARRÉ SYNDROME
UK'S MHRA: CURRENTLY NO EVIDENCE OF INCREASED RISK OF GUILLAIN-BARRÉ SYNDROME IN PREGNANT WOMEN FOLLOWING VACCINATION WITH ABRYSVO